Noom built one of the best-known behavior-change programs in consumer health, and since 2024 its Noom Med arm has sold compounded GLP-1s bundled with that program. Pallas Health comes from the opposite direction: medication-first care with the program layer deliberately optional. Both still offer compounded semaglutide and tirzepatide in 2026 — and both lead with a lower-priced first month — so the real comparison is the program philosophy and a couple of specific numbers.
Pricing on both sides changes often (Noom repriced in July 2026); figures reflect published pricing as of August 2026 — confirm current numbers on both sites before signing up.
The three differences that matter most
- The program is the product at Noom; it's optional at Pallas. Every Noom Med plan includes the full Noom app — psychology-based lessons, tracking, coaching content. You can't buy the medication without the program, and for many people the curriculum is exactly why they choose Noom. Pallas includes no curriculum: licensed clinician, dose management, unlimited portal messaging, and a free tracking app you can use or ignore.
- The semaglutide math. Noom's GLP-1Rx (compounded semaglutide, medication included) is $129 for the first four weeks, then $279/month billed as $837 every 12 weeks. Pallas's compounded semaglutide injection is $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. After the first month that is roughly $80/month apart in Pallas's favor, billed every 4 weeks where Noom bills every 12. On tirzepatide the two are nearly identical: Noom's Plus plan is $149 to start then $299/month ($897 per 12 weeks) — and Pallas's tirzepatide injection is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Both lead with a lower-priced first month; Pallas charges nothing until a clinician prescribes.
- What happens if plans change. Per Noom's published refund policy, once a prescription is written, refunds are no longer possible. Pallas charges only once a clinician prescribes, and you can cancel anytime, self-serve, in the portal.
About compounded medications
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. A licensed clinician decides whether a compounded preparation — for example, a dose level or a formulation a brand-name product doesn't offer — is appropriate for you.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.
Quick comparison
| Pallas Health | Noom Med (GLP-1Rx) | |
|---|---|---|
| Compounded semaglutide injection | Yes — one all-in plan price | Yes — $129 first 4 weeks, then $279/mo ($837/12 wks) |
| Compounded tirzepatide injection | Yes — one all-in plan price | Yes — $149 to start, then $299/mo ($897/12 wks) |
| Behavioral program | Optional free tracking app | Bundled — full Noom app and curriculum included |
| Brand-name support | Dispensed cash-pay from $499/mo (daily pills; weekly pens $499 for the first month, then from $599), no membership | Telehealth track $39 first 30 days → $99/mo; medication billed separately via your insurance/pharmacy |
| Low-dose plans | Not offered | Offered at lower price points |
| States served | All 50 + DC | All states except Alabama, Louisiana, Mississippi |
| If a clinician doesn't prescribe | Nothing charged | Refunds unavailable once a prescription is written, per their policy |
| Cancellation | Anytime, self-serve in portal | Cancel anytime; renewal charges non-refundable |
| Companion app | Free on iOS and Android, no subscription | Included (it's the product) |
| Year founded | 2026 | 2008 (Noom Med launched 2023–24) |
What Noom does well
The behavior-change layer is real. Noom's psychology-based curriculum is the most developed in the industry, and pairing it with medication is a coherent thesis: the habits are what remain when a course of medication ends. If you know you want daily lessons, structured tracking, and a program identity, nobody does it at Noom's scale.
An insurance-friendly brand track. For patients who want brand-name Wegovy®, Zepbound®, Ozempic®, or Mounjaro® through insurance, Noom's telehealth track ($39 for the first 30 days, then $99/month, medication billed separately) plus its insurance-checking tools is a structured way to pursue coverage. Pallas is cash-pay and doesn't route insurance.
An established, accredited operation. Noom has operated since 2008, is BBB-accredited with an A+ rating as of August 2026, and carries one of the largest consumer-review bases in the category. It also still offers compounded GLP-1s — including lower-priced low-dose plans — after most large platforms exited.
What Pallas does differently
Medication-first, and cheaper where it counts most. Pallas's compounded semaglutide runs about $80/month below Noom's ongoing rate, with the same everything-included posture: provider care, dose adjustments, unlimited messaging, shipping. One number — $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. — flat at every dose, no curriculum attached. Pallas's compounded plans are compounded semaglutide and compounded tirzepatide injections, one price with clinician care included.
All 50 states. Noom's compounded plans exclude Alabama, Louisiana, and Mississippi as of August 2026. Pallas serves every state plus DC, asynchronously in most of them.
Charged only if prescribed. Nothing is charged until a clinician prescribes; Noom's published policy stops offering refunds once the prescription is written. Cancel anytime with no cycle mechanics to time.
A free companion app without a subscription attached. The Pallas companion app (iOS and Android) covers protein, steps, weight trend, and dose reminders — a tool, not a program.
Who should pick which
Noom is probably the better fit if:
- You want the psychology curriculum and structured daily program alongside medication — that's Noom's genuine specialty
- You want to pursue brand-name medication through insurance with a guided track
- You're interested in a lower-priced low-dose plan and a clinician judges it appropriate
Pallas is probably the better fit if:
- You want medication-first care at the lower ongoing semaglutide price
- You live in Alabama, Louisiana, or Mississippi — or just want one platform that covers every state
- You want nothing charged unless a clinician prescribes, and cancel-anytime terms
- You prefer async care with anytime provider messaging over a program cadence
Switching between them
Bring your medication name, current dose, and titration history. A new clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. If you're leaving Noom, note that their refund policy treats written prescriptions as final; time your switch at a cycle boundary. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.
Bottom line: Noom sells a program with medication in it — the best behavior-change curriculum in the category, bundled pricing billed every 12 weeks, and an insurance-friendly brand track, from an established A+-rated company. Pallas sells the medication care itself: about $80/month less for compounded semaglutide, matching ongoing tirzepatide pricing, nothing charged until a clinician prescribes, all 50 states, and cancel-anytime terms. If the curriculum is why you're coming, Noom earns it; if the medication care is the point, Pallas prices it better with stronger exit terms.
